Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 2/20 | 0.53 |
| ▸ | CDC25A | P30304 | 1/20 | 0.53 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.50 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.49 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.49 |
| ▸ | TUBB | P07437 | 1/20 | 0.49 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.49 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.49 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.49 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.49 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.49 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10349326 | 1.00 | CES1 (0.53) | CES1CDC25ARXFP1LMNATP53 | |
| SCHEMBL32667803 | 1.00 | CES1 (0.53) | CES1CDC25ARXFP1LMNATP53 | |
| SCHEMBL14281166 | 0.86 | RXFP1 (0.61) | RXFP1LMNATP53POLBMAPT | |
| SCHEMBL11182750 | 0.83 | RXFP1 (0.51) | RXFP1LMNATP53POLBMAPT | |
| SCHEMBL3635173 | 0.82 | CDC25A (0.61) | CES1CDC25ALMNAALDH1A1ALDH2 | |
| SCHEMBL30141987 | 0.82 | CDC25A (0.61) | CES1CDC25ALMNAALDH1A1ALDH2 | |
| SCHEMBL15644072 | 0.80 | ALDH1A1 (0.59) | CES1CDC25ALMNATP53ALDH1A1 | |
| SCHEMBL1302641 | 0.79 | LMNA (0.58) | RXFP1LMNATP53ALDH1A1POLB | |
| SCHEMBL4307189 | 0.78 | RXFP1 (0.61) | RXFP1LMNATP53ALDH1A1POLB | |
| SCHEMBL30433630 | 0.78 | RXFP1 (0.61) | RXFP1LMNATP53ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090252895-A1 | Actinic ray curable composition, actinic ray curable ink and image formation method employing the ink | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-10-08 | — | — | US | disclosed |
| US-20090041945-A1 | ACTIVE RAY CURABLE COMPOSITION, POLYMERIZATION METHOD, ACTIVE RAY CURABLE INK, IMAGE FORMING METHOD, AND INK-JET RECORDING APPARATUS | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-02-12 | — | — | US | disclosed |
| US-20080180501-A1 | Actinic Ray Curable Composition, Actinic Ray Curable Ink, Image Forming Method Utilizing the Same, Ink-Jet Recording Apparatus and Epoxy Compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-07-31 | — | — | US | disclosed |
| US-7405308-B2 | Thianthrenium salt cationic photoinitiators | RENSSELAER POLYTECHNIC INSTITUE (US) | 2008-07-29 | — | — | US | disclosed |
| US-7390840-B2 | Active ray curable composition, active ray curable ink, image forming method and inkjet recording apparatus utilizing the same | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-06-24 | — | — | US | disclosed |
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-05-08 | — | — | US | disclosed |
| US-7360883-B2 | Active ray curable ink, image forming method and ink-jet recording apparatus | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-04-22 | — | — | US | disclosed |
| EP-1840148-A1 | POLYMERIZABLE ACTINIC RADIATION CURABLE COMPOSITION, POLYMERIZATION METHOD, ACTINIC RADIATION CURABLE INK AND IMAGE FORMATION METHOD, AND INK JET RECORDING APPARATUS AND EPOXY COMPOUND | Konica Minolta Medical & Graphic, Inc. (JP) | 2007-10-03 | — | — | EP | disclosed |
| EP-1837357-A1 | ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, METHOD OF IMAGE FORMING THEREWITH, INKJET RECORDING APPARATUS AND EPOXY COMPOUND | Konica Minolta Medical & Graphic, Inc. (JP) | 2007-09-26 | — | — | EP | disclosed |
| EP-1829936-A1 | ACTIVE RAY-CURABLE COMPOSITION, ACTIVE RAY-CURABLE INK AND IMAGE-FORMING METHOD | Konica Minolta Medical & Graphic, Inc. (JP) | 2007-09-05 | — | — | EP | disclosed |
| EP-1486526-B1 | Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method | KONICA MINOLTA MED & GRAPHIC (JP) | 2006-08-16 | — | — | EP | disclosed |
| US-20060105111-A1 | Actinic ray curable composition, actinic ray curable ink and image formation method employing the ink | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2006-05-18 | — | — | US | disclosed |
| US-20050215657-A1 | Active ray curable composition, active ray curable ink, image forming method and inkjet recording apparatus utilizing the same | KONICA MINOLTA MEDICAL & GRAPHIC, INC. | 2005-09-29 | — | — | US | disclosed |
| US-20050209365-A1 | ink jet printing is disclosed, containing a compound represented by the following formula (a-1) or (a-2) and an alicyclic epoxy compound represented by the following formula (b). An image forming method by use thereof is also disclosed | KONICA MINOLTA MEDICAL & GRAPHIC, INC. | 2005-09-22 | — | — | US | disclosed |
| US-20050190252-A1 | Active ray curable ink, image forming method and ink-jet recording apparatus | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2005-09-01 | — | — | US | disclosed |
| US-20050064333-A1 | Thianthrenium salt cationic photoinitiators | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2005-03-24 | — | — | US | disclosed |
| EP-1504306-A1 | PHOTOPOLYMERIZABLE COMPOSITIONS COMPRISING THIANTHRENIUM SALTS AS CATIONIC PHOTOINITIATORS | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2005-02-09 | — | — | EP | disclosed |
| US-20040252171-A1 | Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method | KONICA MINOLTA MEDICAL & GRAPHIC, INC. | 2004-12-16 | — | — | US | disclosed |
| EP-1486526-A1 | Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method | Konica Minolta Medical & Graphic, Inc. (JP) | 2004-12-15 | — | — | EP | disclosed |
| WO-2003098347-A1 | PHOTOPOLYMERIZABLE COMPOSITIONS COMPRISING THIANTHRENIUM SALT CATIONIC PHOTOINITIATORS | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2003-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080180501-A1 | Actinic Ray Curable Composition, Actinic Ray Curable Ink, Image Forming Method Utilizing the Same, Ink-Jet Recording Apparatus and Epoxy Compound | ROCK1, MACF1, ACTN1 | CES1 4319/4885CDC25A 2400/4885RXFP1 676/4885 |
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | CBR3, CBR1, CNR1 | CES1 2969/4885CDC25A 2878/4885RXFP1 946/4885 |
| US-20090041945-A1 | ACTIVE RAY CURABLE COMPOSITION, POLYMERIZATION METHOD, ACTIVE RAY CURABLE INK, IMAGE FORMING METHOD, AND INK-JET RECORDING APPARATUS | RIF1, NAP1L4, NAP1L1 | CES1 4143/4885CDC25A 3193/4885RXFP1 1064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.